FDA faces pressure from the right following approval of abortion pill
Frustration is growing among anti-abortion advocates regarding the FDA’s recent approval of a second version of Mifepristone, a medication used in abortions. After President Trump’s campaign promises to let states decide on abortion policies, these advocates are pressuring him to take more decisive action to restrict Mifepristone’s availability. Despite the pressures, there hasn’t been much […]
FDA approves a new abortion pill after RFK Jr. promised to assess its safety, causing anger among conservatives
The FDA has given the green light to a new generic version of mifepristone, a drug used for abortions, which is being met with backlash. It’s seen by some as a “complete betrayal,” especially after Health Secretary Robert F. Kennedy Jr. promised a thorough safety review of the medication. Evita Solutions, the company producing these […]
Sen. Josh Hawley criticizes the FDA for greenlighting a new chemical abortion medication
FDA Approves New Chemical Abortion Drug Amid Concerns Senator Josh Hawley from Missouri has criticized the Food and Drug Administration (FDA) for approving another chemical abortion drug without a comprehensive safety review, citing risks to women’s health. He emphasized the weak regulatory framework and pointed out that the company involved failed to adequately define “women” […]
Lawmakers Criticize Trump’s FDA for Secretly Approving New Abortion Pill
Several GOP lawmakers criticized the Food and Drug Administration (FDA) after it established a new environment for abortion drugs on Thursday. This wave of backlash followed the FDA’s approval of new abortion pills produced by Evita Solutions, a company that aims “to normalize abortion care” and ensure “that care is accessible to everyone.” “This is […]
FDA discovers radioactive contamination in spices following significant shrimp recalls
Federal regulators have identified potential radioactive contamination in another food shipment from Indonesia to the United States, raising concerns about unusual issues with imports. Officials from the U.S. Food and Drug Administration (FDA) have halted all spice imports from a company called PT Natural Java Spices after detecting cesium-137 in a clove shipment that was […]
FDA starts updating Tylenol labels to include autism warning
The Food and Drug Administration (FDA) revealed on Monday that it has revised the acetaminophen label to indicate potential links between the use of common painkillers during pregnancy and risks such as autism and ADHD in children. This update follows a statement from President Trump, who had publicly advised pregnant women against using Tylenol. “We’ll […]
Trump reveals FDA will modify Tylenol safety label, encourages expectant mothers to reduce autism risk in their children
Trump Advises Against Tylenol Use During Pregnancy In a statement on Monday, President Trump suggested that pregnant women refrain from taking Tylenol, citing research that indicates a potential link between common painkillers and autism. This comes as part of a broader update regarding acetaminophen, with the FDA set to revise the labeling to include warnings […]
Apple Watch Series 11 receives FDA approval for hypertension alerts
Apple Watch Series 11 Unveils FDA-Cleared Hypertension Notifications The World Health Organization reports that approximately 1.3 billion adults globally have hypertension, often without even realizing it. This is where Apple’s new feature might really make a difference. The Apple Watch Series 11 will be rolling out hypertension notifications approved by the FDA. This feature is […]
FDA gives the green light to J&J’s bladder cancer therapy.
The US FDA has granted approval for Johnson & Johnson’s drug delivery system aimed at treating bladder cancer, presenting a potential option for those who want to avoid surgery. Known as Inlexzo, this system is intended for patients with non-muscle invasive bladder cancer who haven’t had success with Bacillus Calmette-Guerin (BCG) therapy, which is the […]
Hims Stock Increases as FDA Releases “Green List,” Novo Nordisk Shares Decrease
Shares of HIMS & HERS (HIMS) increased by 2.6% on Monday following the FDA’s release of a “green list” of global suppliers offering ingredients that meet GLP-1 standards. This announcement indicates that the company will begin to take on compound interest, allowing them to gather active ingredients and create customized versions of GLP-1 weight loss […]